How Pfizer thinks about AI, Thomson 1.0, & Who's Behind Ox Alpha? | 150
Send us Fan Mail A drug company CEO just made the best case yet for why platform choice matters less than most associations think. Marking three years of Sidecar Sync, Amith Nagarajan and Mallory Mejias dig into Pfizer's new playbook for organizing around AI, Thomson Reuters' $40 million bet on building its own legal model instead of renting one, and the six-day mystery of Ox Alpha, an anonymous coding model that became OpenRouter's biggest launch ever. They trace Pfizer CEO Albert Bourla's t...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Sidecar Sync
Will AI End Us All? | 152
Fundamentals of AI, Part 2 | 151
Spirit Airlines' Data Sale, the Model Too Powerful to Ship, & the Landlords of AI | 149
Fundamentals of AI, Part 1 | 148
Get summaries like this every morning.
Free AI-powered recaps of Sidecar Sync and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.